GFAP is a type III intermediate filamentous protein, which exists in monomer form and is mainly distributed in astrocytes of the central nervous system, participating in the construction of the cytoskeleton and maintaining its tensile strength and GFAP is as a potential biomarker for AD (Kim et al., 2023). This evidence concerns the gene GFAP and Alzheimer disease.